FrancophonIA/ELRC3.0 huggingface dataset:
English: If the same intravenous line is used for sequential infusion of several active substances, the line should be flushed before and after infusion of tigecycline with either sodium chloride 9 mg/ml (0.9 %) solution for injection or dextrose 50 mg/ml (5 %) solution for injection.
Croatian: Ukoliko se koristi ista intravenska linija za sekvencijalnu infuziju nekoliko djelatnih tvari, liniju je potrebno isprati prije i poslije infuzije tigeciklina, bilo s otopinom natrijevog klorida od 9 mg/ml (0,9%) za injekciju ili s otopinom glukoze od 50 mg/ml (5%) za injekciju.
English: Consistent with the limited oral bioavailability of tigecycline, there is little or no systemic exposure to tigecycline in the nursing pups as a result of exposure via maternal milk.
Croatian: U skladu s ograničenom oralnom bioraspoloživošću tigeciklina, sistemska izloženost tigeciklinu štenadi koja se hrani mlijekom vrlo je mala ili nikakva.
English: In reproduction toxicity studies, decreased foetal weights in rats and rabbits (with associated delays in ossification) and foetal loss in rabbits have been observed with tigecycline.
Croatian: U ispitivanjima reproduktivne toksičnosti s tigeciklinom opažena je smanjena masa fetusa u štakora i kunića (s povezanom odgođenom osifikacijom) te gubitak fetusa kod kunića.
English: Tetracycline class adverse reactions may include photosensitivity, pseudotumour cerebri, pancreatitis, and antianabolic action which has led to increased BUN, azotaemia, acidosis, and hyperphosphataemia (see section 4.4).
Croatian: Nuspojave tetraciklinskog razreda mogu uključivati fotosenzibilnost, pseudotumor velikog mozga, pankreatitis i antianaboličko djelovanje koje vodi do povišenog BUN-a, azotemije, acidoze i hiperfosfatemije (vidjeti dio 4.4).
English: The vial should be gently swirled until the active substance is dissolved.
Croatian: Bočicu treba nježno vrtjeti sve dok se djelatna tvar ne otopi.
English: Thereafter, the solution should be immediately withdrawn from the vial and added to a 100 ml intravenous bag or other suitable infusion container in the hospital.
Croatian: Nakon toga je potrebno odmah izvući otopinu iz bočice i dodati u intravensku vrećicu od 100 ml ili neki drugi prikladni spremnik za infuziju u bolnici.
English: Anaphylaxis/anaphylactoid reactions, potentially life-threatening, have been reported with tigecycline (see sections 4.3 and 4.8).
Croatian: Pri primjeni tigeciklina prijavljene su anafilaksija/anafilaktoidne reakcije, potencijalno opasne po život (vidjeti dijelove 4.3. i 4.8).
English: Results of studies in rats with tigecycline have shown bone discolouration.
Croatian: Rezultati ispitivanja tigeciklina na štakorima pokazali su promjenu boje kostiju.
English: The effect of cholestasis in the pharmacokinetics of tigecycline has not been properly established.
Croatian: Djelovanje kolestaze na farmakokinetiku tigeciklina nije u cijelosti utvrđen.
English: • Complicated infection in the abdomen
Croatian: • Kompliciranu infekciju u trbuhu.
English: The first study enrolled children aged 8-16 years (n=24) who received single doses of tigecycline (0.5, 1, or 2 mg/kg, up to a maximum dose of 50 mg, 100 mg, and 150 mg, respectively) administered intravenously over 30 minutes.
Croatian: Prvo ispitivanje uključivalo je djecu u dobi od 8 do 16 godina (n=24), koja su primila jednu dozu tigeciklina (0,5, 1, ili 2 mg/kg, do maksimane doze od 50 mg, 100 mg i 150 mg) primijenjenu intravenski kroz 30 minuta.
English: In Phase 3 and 4 cSSTI and cIAI clinical studies, infection-related serious adverse reactions were more frequently reported for subjects treated with tigecycline (7.1 %) vs comparators (5.3 %).
Croatian: U kliničkim ispitivanjima faze 3 i 4 kompliciranih infekcija kože i mekih tkiva i kompliciranih intraabdominalnih infekcija, nuspojave povezane s infekcijom bile su češće zabilježene u ispitanika koji su primali tigeciklin (7,1) u odnosu na bolesnike koji su primali usporedne lijekove (5,3 %).
English: The pH is adjusted with hydrochloric acid, and if necessary sodium hydroxide.
Croatian: Svaka bočica sadrži laktozu hidrat. pH se podešava kloridnom kiselinom te, ako je potrebno, natrijevim hidroksidom.
English: • Injection site reaction (pain, redness, inflammation)
Croatian: • Reakcije na mjestu primjene injekcije (bol, crvenilo, upala)
English: Injection should be made with an infusion solution compatible with tigecycline and any other medicinal product(s) via this common line.
Croatian: Infuzijska otopina koja se primjenjuje treba biti kompatibilna s tigeciklinom i drugim lijekovima koji se daju u zajedničkoj liniji.
English: It is not known if Tygacil passes into breast milk in humans.
Croatian: Nije poznato izlučuje li se Tygacil u majčino mlijeko kod ljudi.
English: Clearance, weight-normalised clearance, and AUC were not appreciably different among patients with different body weights, including those weighing ≥125 kg. AUC was 24 % lower in patients weighing ≥125 kg. No data is available for patients weighing 140 kg and more.
Croatian: Klirens, klirens normaliziran s obzirom na težinu i AUC nisu bili bitno različiti među bolesnicima s različitom tjelesnom težinom, uključujući i one s težinom ≥125 kg.
English: A patient developing impaired healing should be monitored for the detection of superinfection (see section 4.8).
Croatian: Bolesnika u kojeg je prisutno poremećeno zacjeljivanje potrebno je često kontrolirati kako bi se uočila superinfekcija (vidjeti dio 4.8).
English: generalised allergic reaction that may lead to a life-threatening shock [e.g. difficulty in breathing, drop of blood pressure, fast pulse]).
Croatian: • Anafilaktičke/anafilaktoidne reakcije (mogu varirati od blagih do teških, uključujući iznenadne generalizirane alergijske reakcije koje mogu dovesti do životno ugrožavajućeg šoka [tj. poteškoće pri disanju, pad krvnog tlaka, ubrzani puls]).
English: However, polymicrobial intra-abdominal infections have shown to respond to treatment with tigecycline in clinical trials.
Croatian: Međutim, u kliničkim je ispitivanjima dokazano da polimikrobne intraabdominalne infekcije odgovaraju na liječenje tigeciklinom.
English: Tygacil may cause foetal harm.
Croatian: Tygacil može oštetiti plod.
English: The recommended dose in adults is 100 mg given initially, followed by 50 mg every 12 hours.
Croatian: Preporučena početna doza u odraslih iznosi 100 mg, nakon čega slijedi 50 mg svakih 12 sati.
English: Dizziness may occur and this may have an effect on driving and use of machines (see section 4.8).
Croatian: Može se javiti omaglica, koja može utjecati na upravljanje vozilima i rad na strojevima (vidjeti dio
English: General disorders and administration site conditions impaired healing, injection site reaction, headache injection site inflammation, injection site pain, injection site oedema, injection site phlebitis
Croatian: Opći poremećaji i reakcije na mjestu primjene poremećeno zacjeljivanje, reakcija na mjestu injiciranja, glavobolja upala na mjestu injiciranja, bol na mjestu injiciranja, edem na mjestu injiciranja, flebitis na mjestu injiciranja
English: Pseudomembranous colitis has been reported with nearly all antibacterial agents and may range in severity from mild to life threatening.
Croatian: Kod gotovo svih antibakterijskih lijekova opisan je pseudomembranozni kolitis, koji prema težini može varirati od blagog do opasnog po život.
English: Acute pancreatitis, which can be serious, has occurred (frequency: uncommon) in association with tigecycline treatment (see section 4.8).
Croatian: Uz liječenje tigeciklinom može se razviti akutni pankreatitis, koji može biti ozbiljan (učestalost: manje često) (vidjeti dio 4.8).
English: If you miss a dose of Tygacil If you are concerned that you may have missed a dose, talk to your doctor or nurse immediately.
Croatian: Ako Vas brine to da ste možda propustili dozu, odmah razgovarajte s Vašim liječnikom ili medicinskom sestrom.
English: The second study was performed in children aged 8 to 11 years who received multiple doses of tigecycline (0.75, 1, or 1.25 mg/kg up to a maximum dose of 50 mg) every 12 hours administered intravenously over 30 minutes.
Croatian: Drugo ispitivanje provedeno je u djece u dobi od 8 do 11 godina koja su primala višekratne doze tigeciklina (0,75, 1 ili 1,25 mg/kg do maksimalne doze od 50 mg) svakih 12 sati primijenjene intravenski kroz 30 minuta.
English: C-tigecycline, unchanged tigecycline was the primary
Croatian: C-tigeciklina kod zdravih muških dobrovoljaca pokazalo se da je nepromijenjeni tigeciklin predstavljao glavninu
English: • Tell your doctor immediately if you develop symptoms of an allergic reaction.
Croatian: • Ako razvijete simptome alergijske reakcije, o tome odmah obavijestite liječnika.
English: For storage conditions after reconstitution of the medicinal product, see section 6.3.
Croatian: Uvjete čuvanja lijeka pripremljenog za primjenu vidjeti u dijelu 6.3.
English: Parenteral products should be inspected visually for particulate matter and discolouration (e.g. green or black) prior to administration.
Croatian: Parenteralne lijekove treba, prije primjene, vizualno pregledati da ne sadrže čestice ili da nisu promijenili boju (npr. zeleno ili crno).
English: Children aged 8 to <12 years: 1.2 mg/kg of tigecycline every 12 hours intravenously to a maximum dose of 50 mg every 12 hours for 5 to 14 days.
Croatian: Djeca u dobi od 8 do <12 godina: 1,2 mg/kg tigeciklina svakih 12 sati u venu do maksimalne doze od 50 mg svakih 12 sati tijekom 5 do 14 dana.
English: Vascular disorders phlebitis thrombophlebitis
Croatian: Krvožilni poremećaji flebitis tromboflebitis
English: The recommended dose in children aged 8 to <12 years is 1.2 mg/kg given every 12 hours intravenously to a maximum dose of 50 mg every 12 hours.
Croatian: Preporučena doza u djece u dobi od 8 to <12 godina je 1,2 mg/kg koja se daje svakih 12 sati u venu u najvećoj dozi od 50 mg svakih 12 sati.
English: Peptostreptococcus spp.†
Croatian: Clostridium perfringens† Peptostreptococcus spp. † Prevotella spp.
English: ADR identified post-marketing
Croatian: Nuspojava identificirana nakon stavljanja lijeka u promet
English: Pathogens of the family Proteeae (Proteus spp., Providencia spp., and Morganella spp.)
Croatian: Uzročnici iz obitelji Proteeae (Proteus spp., Providencia spp. i Morganella spp.) općenito su manje osjetljivi na tigeciklin od ostalih članova skupine Enterobacteriacea.
English: Tygacil 50 mg powder for solution for infusion
Croatian: Tygacil 50 mg prašak za otopinu za infuziju
English: The powder should be reconstituted with 5.3 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, dextrose 50 mg/ml (5 %) solution for injection, or Lactated Ringer's solution for injection to achieve a concentration of 10 mg/ml of tigecycline.
Croatian: Prašak se mora pripremiti s 5,3 ml otopine natrijevog klorida od 9 mg/ml (0,9%-tnom otopinom) za injekciju, otopinom glukoze od 50 mg/ml (5%) za injekciju ili otopinom Ringerovog laktata, kako bi se postigla koncentracija tigeciklina od 10 mg/ml.
English: Pseudomembranous colitis which may range in severity from mild to life threatening (see section 4.4).
Croatian: Pseudomembranozni kolitis koji može varirati po težini od blagog do opasnog po život (vidjeti dio
English: These effects were observed at exposures of 14 and 3 times the human daily dose based on the AUC in rats and dogs respectively.
Croatian: Navedeni učinci opaženi su prilikom izloženosti dozama koje su bile 14 odnosno 3 puta veće od dnevne doze za ljude, na temelju AUC-a kod štakora odnosno pasa.Nisu opaženi dokazi o fotosenzitivnosti kod štakora nakon primjene tigeciklina.
English: No significant effect of a single intravenous dose of tigecycline 50 mg or 200 mg on QTc interval was detected in a randomized, placebo- and active-controlled four-arm crossover thorough QTc study of 46 healthy subjects.
Croatian: U randomiziranom, placebom i aktivnim lijekom kontroliranom, temeljitom ispitivanju QTc-intervala, s četiri skupine ispitanika i križnom zamjenom skupina, provedenom u 46 zdravih ispitanika, jednokratna intravenska doza tigeciklina od 50 mg ili 200 mg nije imala značajni učinak na QTcinterval.
English: Tygacil 50 mg powder for infusion Tigecycline
Croatian: Tygacil 50 mg prašak za infuziju tigeciklin
English: Dose Normalized to 1 mg/kg Mean ± SD Tigecycline Cmax and AUC in Children Age (yr)
Croatian: Srednje vrijednosti ± SD Cmax i AUC tigeciklina u djece pri dozi normaliziranoj do 1 mg/kg Dob (godina)
English: Sodium hydroxide (for pH adjustment)
Croatian: 6.1 Popis pomoćnih tvari laktoza hidrat kloridna kiselina natrijev hidroksid (za podešavanje pH)
English: There is limited evidence of the clinical efficacy of tigecycline against enterococci.
Croatian: Iskustvo s kliničkom djelotvornošću tigeciklina na enterokoke je ograničeno.
English: Thereafter, 5 ml of the reconstituted solution should be immediately withdrawn from the vial and added to a 100 ml intravenous bag for infusion or other suitable infusion container (e.g. glass bottle).
Croatian: Nakon toga se odmah iz bočice mora izvući 5 ml pripremljene otopine i dodati u vrećicu za intravensku infuziju od 100 ml ili neki drugi prikladni infuzijski spremnik (npr. staklenu bocu).
English: Compatible intravenous solutions include: sodium chloride 9 mg/ml (0.9 %) solution for injection, dextrose 50 mg/ml (5 %) solution for injection, and Lactated Ringer's solution for injection.
Croatian: Kompatibilne intravenske otopine uključuju: natrijev klorid 9 mg/ml (0,9%) otopinu za injekciju, glukoza 50 mg/ml (5%) otopinu za injekciju i otopinu za injekciju Ringerovog laktata.
English: Via Franco Gorgone Z.I.
Croatian: Wyeth Lederle S.r.l. Via Franco Gorgone Z.I. 95100 Catania (CT) Italija
English: Κύπρος
Croatian: Kύπρος
English: For a 100 mg dose, reconstitute using two vials into a 100 ml intravenous bag for infusion or other suitable infusion container (e.g. glass bottle).
Croatian: Za dozu od 100 mg, pripremite dvije bočice u infuzijskoj vrećici od 100 ml ili nekom drugom prikladnom infuzijskom spremniku (npr. staklenoj boci).
English: Each 5 ml Tygacil vial contains 50 mg of tigecycline.
Croatian: Jedna bočica Tygacila od 5 ml sadrži 50 mg tigeciklina.
English: Prothrombin time or other suitable anticoagulation test should be used to monitor patients if tigecycline is administered with anticoagulants (see section 4.5).
Croatian: U slučaju istovremene primjene tigeciklina s antikoagulansima, potrebno je pratiti protrombinsko vrijeme ili neki drugi prikladni koagulacijski parametar u ovih bolesnika (vidjeti dio 4.5).
English: Tygacil 50 mg powder for solution for infusion Tigecycline
Croatian: Tygacil 50 mg prašak za otopinu za infuziju tigeciklin
English: other than S. pneumoniae S  0.25 mg/L and R  0.5 mg/L Enterococcus spp.
Croatian: Staphylococcus spp., S 0,5 mg/l i R >0,5 mg/l Streptococcus spp., s iznimkom S. pneumoniae S 0,25 mg/l i R >0,5 mg/l Enterococcus spp., S 0,25 mg/l i R >0,5 mg/l Enterobacteriaceae
English: Pseudomembranous colitis may occur with most antibiotics including Tygacil.
Croatian: Pri primjeni većine antibiotika, uključujući i Tygacil, može nastati pseudomembranozni kolitis.
English: Tigecycline may be associated with permanent tooth discolouration if used during tooth development (see section 4.4).
Croatian: Ako se tigeciklin primjenjuje tijekom razdoblja razvoja zubi njegovo djelovanje može biti povezano s trajnom promjenom boje zubi (vidjeti dio 4.4).
English: Multiple dose
Croatian: Višekratna doza
English: Each vial contains 50 mg tigecycline.
Croatian: Jedna bočica sadrži 50 mg tigeciklina.
English: Consideration should be given to the cessation of the treatment with tigecycline in cases suspected of having developed pancreatitis.
Croatian: U slučajevima sumnje na razvijeni pankreatitis treba uzeti u obzir prekid terapije s tigeciklinom.
English: Adverse reactions reported with tigecycline, including clinical trials and post-marketing experience, are tabulated below.
Croatian: Niže su tablično prikazane nuspojave zabilježene uz primjenu tigeciklina u kliničkim ispitivanjima i prema iskustvu nakon stavljanja lijeka u promet.
English: hypofibrinogenaemia
Croatian: Hipofibrinogenemij a
English: Tigecycline is a substrate of P-gp based on an in vitro study using a cell line overexpressing P-gp.
Croatian: Temeljem podataka dobivenim in vitro ispitivanjem stanične linije s prekomjerno izraženim P-gp, tigeciklin je P-gp supstrat.
English: Therefore, patients presenting with cholestasis should be closely monitored.
Croatian: Stoga su potrebne česte kontrole u bolesnika sa simptomima i znakovima kolestaze.
English: How Tygacil is given
Croatian: Što Tygacil sadrži
English: Pfizer Luxembourg SARL Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana Tel.: + 386 (0) 1 52 11 400
Croatian: Pfizer Luxembourg SARL Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana
English: The total number of cSSTI and cIAI patients treated with tigecycline in Phase 3 and 4 clinical studies was 2,393.
Croatian: Ukupni broj bolesnika s kompliciranim infekcijama kože i mekih tkiva i kompliciranim intraabdominalnim infekcijama liječenih tigeciklinom u kliničkim ispitivanjima faze 3 i 4 iznosio je
English: What Tygacil contains The active substance is tigecycline.
Croatian: Djelatna tvar je tigeciklin.
English: Riximyo is indicated in adults for the following indications:
Croatian: Riximyo je indiciran u odraslih u sljedećim indikacijama:
English: Contents of the pack and other information What Riximyo contains
Croatian: Sadržaj pakiranja i druge informacije Što Riximyo sadrži
English: Riximyo may also cause changes in laboratory tests carried out by your doctor.
Croatian: Riximyo može uzrokovati i promjene u nalazima laboratorijskih pretraga koje provodi Vaš liječnik.
English: • Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.
Croatian: • prilikom svake izmjene sustava za upravljanje rizicima, a naročito kada je ta izmjena rezultat primitka novih informacija koje mogu voditi ka značajnim izmjenama omjera korist/rizik odnosno kada je izmjena rezultat ostvarenja nekog važnog cilja (u smislu farmakovigilancije ili minimizacije rizika).
English: Patients should receive Riximyo for at least 24 months after achievement of remission (absence of clinical signs and symptoms).
Croatian: Bolesnici trebaju primati Riximyo najmanje 24 mjeseca nakon postizanja remisije (odsutnost kliničkih znakova i simptoma bolesti).
English: Do not have Riximyo if you have an active infection or a serious problem with your immune system.
Croatian: Ne smijete primiti lijek Riximyo ako imate aktivnu infekciju ili ozbiljne poteškoće s imunološkim sustavom.
English: 6336 Langkampfen Austria
Croatian: 6336 Langkampfen AUSTRIJA
English: 6336 Langkampfen AUSTRIA
Croatian: 6336 Langkampfen Austrija
English: This is because in a few cases, Riximyo could cause hepatitis B to become active again, which can be fatal in very rare cases.
Croatian: Naime, u nekim slučajevima Riximyo može ponovno aktivirati hepatitis B, što u vrlo rijetkim slučajevima može biti smrtonosno.
English: If you can get pregnant, you and your partner must use an effective method of contraception while using Riximyo.
Croatian: Ako ste u dobi kada možete zatrudnjeti, Vi i Vaš partner morate koristiti učinkovitu kontracepciju tijekom liječenja lijekom Riximyo.
English: Your doctor may decide to stop your Riximyo treatment if these reactions are serious.
Croatian: Liječnik može odlučiti prekinuti liječenje lijekom Riximyo ako su te reakcije ozbiljne.
English: Other medicines and Riximyo
Croatian: Drugi lijekovi i Riximyo
English: What Riximyo looks like and contents of the pack
Croatian: Kako Riximyo izgleda i sadržaj pakiranja
English: When should I not have Riximyo?
Croatian: Kada ne smijem primiti lijek Riximyo?
English: For these reasons Riximyo should not be administered to pregnant women unless the possible benefit outweighs the potential risk.
Croatian: Zbog tih se razloga Riximyo ne smije primjenjivati u trudnica, osim ako moguća korist od liječenja nadilazi potencijalni rizik.
English: Riximyo can be given alone or with other medicines called “chemotherapy”.
Croatian: Riximyo se može primjenjivati samostalno ili s drugim lijekovima koji se nazivaju „kemoterapijom“.
English: Riximyo in combination with chemotherapy destroys these cells which are gradually removed from the body by biological processes.
Croatian: Riximyo u kombinaciji s kemoterapijom uništava te stanice koje se postupno uklanjaju iz tijela biološkim procesima.
English: Do not have Riximyo if any of the above apply to you.
Croatian: Nemojte primiti lijek Riximyo ako se nešto od navedenoga odnosi na Vas.
English: Efficacy was observed both for patients with newly diagnosed disease and for patients with relapsing disease (Table 13).
Croatian: Djelotvornost je opažena i u bolesnika s novodijagnosticiranom bolešću i u bolesnika s relapsirajućom bolešću (Tablica 13).
English: Table 12 Percentage of patients who achieved complete remission at 6 months (intent-to-treat population*)
Croatian: Tablica 12 Postotak bolesnika koji su postigli potpunu remisiju nakon 6 mjeseci (populacija s namjerom liječenja*)
English: Your doctor will check if you should have any vaccines before you receive Riximyo.
Croatian: Vaš će liječnik provjeriti morate li primiti neko cjepivo prije nego što primite lijek Riximyo.
English: If you are having Riximyo with other medicines, some of the side effects you may get may be due to the other medicines.
Croatian: Ako lijek Riximyo primate zajedno s drugim lijekovima, neke od nuspojava koje će se možda pojaviti mogu biti uzrokovane drugim lijekovima.
English: Rarely Riximyo can cause a serious brain infection, called “Progressive Multifocal Leukoencephalopathy” or PML.
Croatian: Riximyo rijetko može uzrokovati ozbiljnu infekciju mozga koja se naziva 'progresivna multifokalna leukoencefalopatija' ili PML.
English: Depending on the severity of the IRR and the required interventions, temporarily or permanently discontinue Riximyo.
Croatian: Ovisno o težini infuzijske reakcije i potrebnim intervencijama valja privremeno ili trajno prekinuti primjenu lijeka Riximyo.
English: Riximyo should be administered under the close supervision of an experienced healthcare professional, and in an environment where full resuscitation facilities are immediately available (see section 4.4).
Croatian: Riximyo se treba primjenjivati pod izravnim nadzorom iskusnog zdravstvenog radnika i u okruženju u kojem su izravno dostupni svi uređaji za oživljavanje (vidjeti dio 4.4).
English: Riximyo is a biosimilar medicinal product.
Croatian: Riximyo je biosličan lijek.
English: However, response rates to non- live vaccines may be reduced.
Croatian: Međutim, stope odgovora na neživo cjepivo mogu biti smanjene.
English: < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000) and very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Croatian: (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000) i vrlo rijetko (< 1/10 000) i nepoznato (ne može se procijeniti iz dostupnih podataka).
English: The European Medicines Agency has waived the obligation to submit the results of studies with rituximab in all subsets of the paediatric population with follicular lymphoma and chronic lymphocytic leukaemia.
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja rituksimaba u svim podskupinama pedijatrijske populacije s folikularnim limfomom i kroničnom limfocitnom leukemijom.
English: • If you respond well to treatment, you may be given Riximyo as a maintenance treatment every 2 or 3 months for two years.
Croatian: • Ako dobro odgovorite na liječenje, možda ćete primati lijek Riximyo kao terapiju održavanja svaka 2 ili 3 mjeseca tijekom dvije godine.